Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
39.15 USD | +0.67% | +2.17% | +2.22% |
May. 08 | Stifel Cuts Price Target on Astrana Health to $45 From $50, Maintains Buy Rating | MT |
May. 07 | Transcript : Astrana Health, Inc., Q1 2024 Earnings Call, May 07, 2024 |
Financials (USD)
Sales 2024 * | 1.76B | Sales 2025 * | 2.15B | Capitalization | 1.9B |
---|---|---|---|---|---|
Net income 2024 * | 72M | Net income 2025 * | 86M | EV / Sales 2024 * | 1.03 x |
Net cash position 2024 * | 77.7M | Net cash position 2025 * | 173M | EV / Sales 2025 * | 0.8 x |
P/E ratio 2024 * |
26.5
x | P/E ratio 2025 * |
22.7
x | Employees | 1,800 |
Yield 2024 * |
0.32% | Yield 2025 * |
0.4% | Free-Float | 72.5% |
Latest transcript on Astrana Health, Inc.
1 day | +0.67% | ||
1 week | +2.17% | ||
Current month | +5.38% | ||
1 month | -3.86% | ||
3 months | +7.73% | ||
6 months | +24.88% | ||
Current year | +2.22% |
Managers | Title | Age | Since |
---|---|---|---|
Kenneth Sim
FOU | Founder | 70 | 85-10-31 |
Brandon Sim
CEO | Chief Executive Officer | 30 | 19-05-31 |
Thomas Lam
FOU | Founder | 74 | 85-10-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Wei Li Dai
BRD | Director/Board Member | 62 | 21-12-30 |
Director/Board Member | 67 | 17-12-07 | |
Director/Board Member | 67 | 19-09-28 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.14% | 43 M€ | +3.66% |
Date | Price | Change | Volume |
---|---|---|---|
24-05-13 | 39.15 | +0.67% | 114,254 |
24-05-10 | 38.89 | -0.41% | 145,566 |
24-05-09 | 39.05 | +2.52% | 147,609 |
24-05-08 | 38.09 | +0.42% | 158,669 |
24-05-07 | 37.93 | -1.02% | 125,527 |
Delayed Quote Nasdaq, May 13, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+2.22% | 1.9B | |
+17.18% | 85.55B | |
-28.48% | 70.07B | |
+6.76% | 28.95B | |
-7.44% | 17.51B | |
+2.14% | 17.39B | |
+2.10% | 15.38B | |
+7.02% | 13.4B | |
+64.96% | 12.93B | |
+6.64% | 12.77B |
- Stock Market
- Equities
- ASTH Stock